Arete Wealth Advisors’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$458K	Buy	90,444 +77,650	+607%	+$393K	0.03%	433
2025 Q1	$68K	Buy	12,794 +1,138	+10%	+$6.05K	0.01%	699
2024 Q4	$78K	Hold	11,656	–	–	0.01%	725
2024 Q3	$77K	Buy	+11,656	New	+$77K	0.01%	683